Prise en charge des exacerbations de BPCO - SFMU

URGENCES
2008
co-fondateurs
Références bibliographiques
1. SPILF. XV e conférence de consensus en thérapeutique anti-infectieuse. Prise en
charge des infections des voies respiratoires basses de l'adulte immunocompétent.
2006.
2. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered
outcomes. Chest 2007 ; 131 (3) : 696-704.
3. Schumaker GL, Epstein SK. Managing acute respiratory failure during exacerbation
of chronic obstructive pulmonary disease. Respir Care 2004 ; 49 (7) : 766-82.
4. Stolz D, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled
trial comparing procalcitonin-guidance with standard therapy. Chest 2007 ;
131 (1) : 9-19.
5. SPLF. Actualisation des recommandations de la SPLF pour la prise en charge de la
BPCO. 2003 : Rev Mal Resp.
6. GOLD. Global strategy for the diagnosis management and prevention of chronic
obstructive pulmonary disease. 2006 : www.goldcop.com
7. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with
COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 ; 23 (6) :
932-46.
8. NICE. Guideline-chronic obstructive pulmonary disease. 2006.
9. Stockley RA, et al. Relationship of sputum color to nature and outpatient management
of acute exacerbations of COPD. Chest 2000 ; 117 (6) : 1638-45.
10. Rutschmann OT, et al. Should pulmonary embolism be suspected in exacerbation of
chronic obstructive pulmonary disease? Thorax 2007 ; 62 (2) : 121-5.
11. Tillie-Leblond I, et al. Pulmonary embolism in patients with unexplained exacerbation
of chronic obstructive pulmonary disease: prevalence and risk factors. Ann
Intern Med 2006 ; 144 (6) : 390-6.
12. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients
with coexistent chronic obstructive pulmonary disease and chronic heart failure. J
Am Coll Cardiol 2007 ; 49 (2) : 171-80.
13. Abroug F, et al. Association of left-heart dysfunction with severe exacerbation of
chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
Am J Respir Crit Care Med 2006 ; 174 (9) : 990-6.
14. Ram FS, et al. Hospital at home for patients with acute exacerbations of chronic
obstructive pulmonary disease: systematic review of evidence. Bmj 2004 ; 329
(7461) : 315.
15. Hernandez C, et al. Home hospitalisation of exacerbated chronic obstructive pulmonary
disease patients. Eur Respir J 2003 ; 21 (1) : 58-67.
16. Rodriguez-Roisin R. COPD exacerbations. 5: management. Thorax 2006 ; 61 (6) :
535-44.
17. McCrory DC, Brown CD. Anti-cholinergic bronchodilators versus beta2-sympathomimetic
agents for acute exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev 2002 ; 4 : CD003900.
18. Turner MO, et al. Bronchodilator delivery in acute airflow obstruction. A meta-analysis.
Arch Intern Med 1997 ; 157 (15) : 1736-44.
19. Wood-Baker RR, et al. Systemic corticosteroids for acute exacerbations of chronic
obstructive pulmonary disease. Cochrane Database Syst Rev 2005 ; 1 : CD001288.
492
■ DÉCOMPENSATION BPCO